$128 Million is the total value of Michelson Medical Research Foundation, Inc.'s 21 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 32.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HYG | ISHARES TRiboxx hi yd etf | $19,275,072 | +2.6% | 255,130 | 0.0% | 15.11% | +24.2% | |
| VEA | VANGUARD TAX-MANAGED FDSvan ftse dev mkt | $13,816,374 | +7.6% | 305,875 | 0.0% | 10.83% | +30.3% | |
| BSV | Buy | VANGUARD BD INDEX FDSshort trm bond | $12,608,994 | +132.7% | 164,845 | +129.1% | 9.89% | +181.8% |
| BKLN | Buy | INVESCO EXCH TRADED FD TR IIsr ln etf | $12,492,688 | +794.5% | 600,610 | +549.1% | 9.80% | +982.4% |
| VWO | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $9,559,852 | +3.6% | 236,630 | 0.0% | 7.50% | +25.5% | |
| IVE | Sell | ISHARES TRs&p 500 val etf | $7,877,103 | -41.7% | 51,905 | -44.2% | 6.18% | -29.4% |
| AVB | AVALONBAY CMNTYS INC | $7,476,149 | +4.0% | 44,485 | 0.0% | 5.86% | +26.0% | |
| HDV | Sell | ISHARES TRcore high dv etf | $7,445,578 | -45.6% | 73,240 | -44.2% | 5.84% | -34.2% |
| IVV | Sell | ISHARES TRcore s&p500 etf | $7,394,918 | -42.9% | 17,989 | -46.6% | 5.80% | -30.9% |
| IBB | ISHARES TRishares biotech | $5,604,898 | -1.6% | 43,395 | 0.0% | 4.40% | +19.1% | |
| PLD | PROLOGIS INC. | $5,290,872 | +10.7% | 42,405 | 0.0% | 4.15% | +34.0% | |
| ARE | ALEXANDRIA REAL ESTATE EQ IN | $4,675,716 | -13.8% | 37,230 | 0.0% | 3.67% | +4.4% | |
| PFF | ISHARES TRpfd and incm sec | $2,559,103 | +2.3% | 81,970 | 0.0% | 2.01% | +23.8% | |
| XBI | SPDR SER TRs&p biotech | $2,385,373 | -8.2% | 31,300 | 0.0% | 1.87% | +11.1% | |
| CRC | CALIFORNIA RES CORP | $2,250,325 | -11.5% | 58,450 | 0.0% | 1.76% | +7.2% | |
| TALO | TALOS ENERGY INC | $2,074,335 | -21.4% | 139,780 | 0.0% | 1.63% | -4.8% | |
| CRESCENT ENERGY COMPANY | $1,766,237 | -5.7% | 156,166 | 0.0% | 1.38% | +14.2% | ||
| BXP | BOSTON PROPERTIES INC | $1,176,298 | -19.9% | 21,735 | 0.0% | 0.92% | -3.0% | |
| NML | NEUBERGER BERMAN MLP & ENERG | $761,279 | -1.4% | 115,872 | 0.0% | 0.60% | +19.4% | |
| RICE ACQUISITION CORP II | $522,292 | +0.6% | 51,030 | 0.0% | 0.41% | +22.0% | ||
| ORION BIOTECH OPPORTUNTES CO | $519,479 | +1.8% | 50,780 | 0.0% | 0.41% | +23.0% | ||
| RSX | Exit | VANECK ETF TRUSTvaneck russia et | $0 | – | -105,000 | -100.0% | -0.07% | – |
| ANAC | Exit | ARCTOS NORTHSTAR ACQUIS CORP | $0 | – | -49,601 | -100.0% | -0.32% | – |
| LDHA | Exit | LDH GROWTH CORP I | $0 | – | -50,826 | -100.0% | -0.33% | – |
| WPCB | Exit | WARBURG PINCUS CAPTAL CORP I | $0 | – | -50,922 | -100.0% | -0.33% | – |
| MSDA | Exit | MSD ACQUISITION CORP | $0 | – | -51,030 | -100.0% | -0.33% | – |
| WPCA | Exit | WARBURG PINCUS CAPTAL CORP I | $0 | – | -50,905 | -100.0% | -0.33% | – |
| ROSS | Exit | ROSS ACQUISITION CORP II | $0 | – | -50,855 | -100.0% | -0.33% | – |
| OAS | Exit | CHORD ENERGY CORPORATION | $0 | – | -20,400 | -100.0% | -1.81% | – |
| ERF | Exit | ENERPLUS CORP | $0 | – | -195,420 | -100.0% | -2.23% | – |
| VNQ | Exit | VANGUARD INDEX FDSreal estate etf | $0 | – | -226,480 | -100.0% | -12.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 4 | Q3 2023 | 15.1% |
| VANGUARD TAX-MANAGED FDS | 4 | Q3 2023 | 10.8% |
| VANGUARD BD INDEX FDS | 4 | Q3 2023 | 9.9% |
| INVESCO EXCH TRADED FD TR II | 4 | Q3 2023 | 9.8% |
| VANGUARD INTL EQUITY INDEX F | 4 | Q3 2023 | 7.5% |
| ISHARES TR | 4 | Q3 2023 | 8.7% |
| ISHARES TR | 4 | Q3 2023 | 8.4% |
| ISHARES TR | 4 | Q3 2023 | 8.9% |
| AVALONBAY CMNTYS INC | 4 | Q3 2023 | 6.0% |
| ISHARES TR | 4 | Q3 2023 | 4.4% |
View Michelson Medical Research Foundation, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
View Michelson Medical Research Foundation, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.